Comprehensive survey of CNVs influencing gene expression in the human brain and its implications for pathophysiology

Neuroscience Research

Volumn 79, Issue 1, 2014, Pages 22-33

  Mehta, Divya ^a,b,e   Iwamoto, Kazuya ^c   Ueda, Junko ^b   Bundo, Miki ^c   Adati, Naoki ^d,f   Kojima, Toshio ^d,g   Kato, Tadafumi ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Bipolar disorder; Copy number variation (CNV); Genomics; Human post mortem brains; Schizophrenia; Transcriptome

Indexed keywords

ARTICLE; BIPOLAR DISORDER; BRAIN TISSUE; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GLUTATHIONE METABOLISM; HUMAN; MENTAL DISEASE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

BIPOLAR DISORDER; COPY NUMBER VARIATION (CNV); GENOMICS; HUMAN POST-MORTEM BRAINS; SCHIZOPHRENIA; TRANSCRIPTOME;

BIPOLAR DISORDER; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION; HUMANS; MALE; PREFRONTAL CORTEX; SCHIZOPHRENIA;

EID: 84896807006     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.10.009     Document Type: Article

References (31)

1. Altar C.A., Hunt R.A., Jurata L.W., Webster M.J., Derby E., Gallagher P., Lemire A., Brockman J., Laeng P. Insulin, IGF-1, and muscarinic agonists modulate schizophrenia-associated genes in human neuroblastoma cells. Biol. Psychiatry 2008, 64:1077-1087.
2. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol. 2001, 14:123-130.
3. Gibbs J.R., van der Brug M.P., Hernandez D.G., Traynor B.J., Nalls M.A., Lai S.L., Arepalli S., Dillman A., Rafferty I.P., Troncoso J., Johnson R., Zielke H.R., Ferrucci L., Longo D.L., Cookson M.R., Singleton A.B. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010, 6:e1000952.
4. Guilmatre A., Dubourg C., Mosca A.L., Legallic S., Goldenberg A., Drouin-Garraud V., Layet V., Rosier A., Briault S., Bonnet-Brilhault F., Laumonnier F., Odent S., Le Vacon G., Joly-Helas G., David V., Bendavid C., Pinoit J.M., Henry C., Impallomeni C., Germano E., Tortorella G., Di Rosa G., Barthelemy C., Andres C., Faivre L., Frebourg T., Saugier Veber P., Campion D. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 2009, 66:947-956.
5. Haraksingh R.R., Abyzov A., Gerstein M., Urban A.E., Snyder M. Genome-wide mapping of copy number variation in humans: comparative analysis of high resolution array platforms. PLoS ONE 2011, 6:e27859.
6. Hedges D.J., Hamilton-Nelson K.L., Sacharow S.J., Nations L., Beecham G.W., Kozhekbaeva Z.M., Butler B.L., Cukier H.N., Whitehead P.L., Ma D., Jaworski J.M., Nathanson L., Lee J.M., Hauser S.L., Oksenberg J.R., Cuccaro M.L., Haines J.L., Gilbert J.R., Pericak-Vance M.A. Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci. Mol. Autism 2012, 3:2.
7. Ingason A., Rujescu D., Cichon S., Sigurdsson E., Sigmundsson T., Pietilainen O.P., Buizer-Voskamp J.E., Strengman E., Francks C., Muglia P., Gylfason A., Gustafsson O., Olason P.I., Steinberg S., Hansen T., Jakobsen K.D., Rasmussen H.B., Giegling I., Moller H.J., Hartmann A., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Bramon E., Kiemeney L.A., Franke B., Murray R., Vassos E., Toulopoulou T., Muhleisen T.W., Tosato S., Ruggeri M., Djurovic S., Andreassen O.A., Zhang Z., Werge T., Ophoff R.A., Investigators G., Rietschel M., Nothen M.M., Petursson H., Stefansson H., Peltonen L., Collier D., Stefansson K., St Clair D.M. Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol. Psychiatry 2011, 16:17-25.
8. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
9. Ionita-Laza I., Rogers A.J., Lange C., Raby B.A., Lee C. Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics 2009, 93:22-26.
10. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005, 14:241-253.
11. Iwamoto K., Ueda J., Bundo M., Kojima T., Kato T. Survey of the effect of genetic variations on gene expression in human prefrontal cortex and its application to genetics of psychiatric disorders. Neurosci. Res. 2011, 70:238-242.
12. Kanahara N., Iyo M., Hashimoto K. Failure to confirm the association between the PIK4CA gene and schizophrenia in a Japanese population. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:450-452.
13. Lanktree M.B., Anand S.S., Yusuf S., Hegele R.A., Investigators S. Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. J. Lipid Res. 2009, 50:1487-1496.
14. Levinson D.F., Duan J., Oh S., Wang K., Sanders A.R., Shi J., Zhang N., Mowry B.J., Olincy A., Amin F., Cloninger C.R., Silverman J.M., Buccola N.G., Byerley W.F., Black D.W., Kendler K.S., Freedman R., Dudbridge F., Pe'er I., Hakonarson H., Bergen S.E., Fanous A.H., Holmans P.A., Gejman P.V. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am. J. Psychiatry 2011, 168:302-316.
15. Lipson D., Aumann Y., Ben-Dor A., Linial N., Yakhini Z. Efficient calculation of interval scores for DNA copy number data analysis. J. Comput. Biol. 2006, 13:215-228.
16. Luo R., Sanders S.J., Tian Y., Voineagu I., Huang N., Chu S.H., Klei L., Cai C., Ou J., Lowe J.K., Hurles M.E., Devlin B., State M.W., Geschwind D.H. Genome-wide transcriptome profiling reveals the functional impact of rare de novo and recurrent CNVs in autism spectrum disorders. Am. J. Hum. Genet. 2012, 91:38-55.
17. McCarthy S.E., Makarov V., Kirov G., Addington A.M., McClellan J., Yoon S., Perkins D.O., Dickel D.E., Kusenda M., Krastoshevsky O., Krause V., Kumar R.A., Grozeva D., Malhotra D., Walsh T., Zackai E.H., Kaplan P., Ganesh J., Krantz I.D., Spinner N.B., Roccanova P., Bhandari A., Pavon K., Lakshmi B., Leotta A., Kendall J., Lee Y.H., Vacic V., Gary S., Iakoucheva L.M., Crow T.J., Christian S.L., Lieberman J.A., Stroup T.S., Lehtimaki T., Puura K., Haldeman-Englert C., Pearl J., Goodell M., Willour V.L., Derosse P., Steele J., Kassem L., Wolff J., Chitkara N., McMahon F.J., Malhotra A.K., Potash J.B., Schulze T.G., Nothen M.M., Cichon S., Rietschel M., Leibenluft E., Kustanovich V., Lajonchere C.M., Sutcliffe J.S., Skuse D., Gill M., Gallagher L., Mendell N.R., Wellcome Trust Case Control Consortium, Craddock N., Owen M.J., O'Donovan M.C., Shaikh T.H., Susser E., Delisi L.E., Sullivan P.F., Deutsch C.K., Rapoport J., Levy D.L., King M.C., Sebat J. Microduplications of 16p11.2 are associated with schizophrenia. Nat. Genet. 2009, 41:1223-1227.
18. Moreno-De-Luca D., Consortium S., Mulle J.G., Simons Simplex Collection Genetics Consortium, Kaminsky E.B., Sanders S.J., GeneStar, Myers S.M., Adam M.P., Pakula A.T., Eisenhauer N.J., Uhas K., Weik L., Guy L., Care M.E., Morel C.F., Boni C., Salbert B.A., Chandrareddy A., Demmer L.A., Chow E.W., Surti U., Aradhya S., Pickering D.L., Golden D.M., Sanger W.G., Aston E., Brothman A.R., Gliem T.J., Thorland E.C., Ackley T., Iyer R., Huang S., Barber J.C., Crolla J.A., Warren S.T., Martin C.L., Ledbetter D.H. Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am. J. Hum. Genet. 2010, 87:618-630.
19. Ng F., Berk M., Dean O., Bush A.I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 2008, 11:851-876.
20. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
21. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
22. Saito T., Stopkova P., Diaz L., Papolos D.F., Boussemart L., Lachman H.M. Polymorphism screening of PIK4CA: possible candidate gene for chromosome 22q11-linked psychiatric disorders. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2003, 116B:77-83.
23. Schlattl A., Anders S., Waszak S.M., Huber W., Korbel J.O. Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions. Genome Res. 2011, 21:2004-2013.
24. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., Hansen T., Jakobsen K.D., Muglia P., Francks C., Matthews P.M., Gylfason A., Halldorsson B.V., Gudbjartsson D., Thorgeirsson T.E., Sigurdsson A., Jonasdottir A., Jonasdottir A., Bjornsson A., Mattiasdottir S., Blondal T., Haraldsson M., Magnusdottir B.B., Giegling I., Moller H.J., Hartmann A., Shianna K.V., Ge D., Need A.C., Crombie C., Fraser G., Walker N., Lonnqvist J., Suvisaari J., Tuulio-Henriksson A., Paunio T., Toulopoulou T., Bramon E., Di Forti M., Murray R., Ruggeri M., Vassos E., Tosato S., Walshe M., Li T., Vasilescu C., Muhleisen T.W., Wang A.G., Ullum H., Djurovic S., Melle I., Olesen J., Kiemeney L.A., Franke B., Group Sabatti C., Freimer N.B., Gulcher J.R., Thorsteinsdottir U., Kong A., Andreassen O.A., Ophoff R.A., Georgi A., Rietschel M., Werge T., Petursson H., Goldstein D.B., Nothen M.M., Peltonen L., Collier D.A., St Clair D., Stefansson K. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
25. Stranger B.E., Forrest M.S., Dunning M., Ingle C.E., Beazley C., Thorne N., Redon R., Bird C.P., de Grassi A., Lee C., Tyler-Smith C., Carter N., Scherer S.W., Tavare S., Deloukas P., Hurles M.E., Dermitzakis E.T. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315:848-853.
26. Vorstman J.A., Chow E.W., Ophoff R.A., van Engeland H., Beemer F.A., Kahn R.S., Sinke R.J., Bassett A.S. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:430-433.
27. Wang J.F., Shao L., Sun X., Young L.T. Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J. Neurochem. 2004, 88:1477-1484.
28. Weischenfeldt J., Symmons O., Spitz F., Korbel J.O. Phenotypic impact of genomic structural variation: insights from and for human disease. Nat. Rev. Genet. 2013, 142:125-138.
29. Weiss L.A., Shen Y., Korn J.M., Arking D.E., Miller D.T., Fossdal R., Saemundsen E., Stefansson H., Ferreira M.A., Green T., Platt O.S., Ruderfer D.M., Walsh C.A., Altshuler D., Chakravarti A., Tanzi R.E., Stefansson K., Santangelo S.L., Gusella J.F., Sklar P., Wu B.L., Daly M.J., Autism C. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 2008, 358:667-675.
30. Ye T., Lipska B.K., Tao R., Hyde T.M., Wang L., Li C., Choi K.H., Straub R.E., Kleinman J.E., Weinberger D.R. Analysis of copy number variations in brain DNA from patients with schizophrenia and other psychiatric disorders. Biol. Psychiatry 2012, 72:651-654.
31. Zhang D., Cheng L., Qian Y., Alliey-Rodriguez N., Kelsoe J.R., Greenwood T., Nievergelt C., Barrett T.B., McKinney R., Schork N., Smith E.N., Bloss C., Nurnberger J., Edenberg H.J., Foroud T., Sheftner W., Lawson W.B., Nwulia E.A., Hipolito M., Coryell W., Rice J., Byerley W., McMahon F., Schulze T.G., Berrettini W., Potash J.B., Belmonte P.L., Zandi P.P., McInnis M.G., Zollner S., Craig D., Szelinger S., Koller D., Christian S.L., Liu C., Gershon E.S. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol. Psychiatry 2009, 14:376-380.